By further analyzing the gut microbiota and BAs in paired samples, we demonstrated that alterations in the gut mucosal microbiota led to CRC progression by metabolizing DCA, which inhibits the expression of the farnesoid X receptor (FXR). Here, NR1H4 is linked to colorectal carcinoma.